← Insider buys
KITE

Kite Pharma, Inc.

EVP, Business Development Helen Susan Kim sold $570K of Kite Pharma, Inc.

Sold$569,714
$179.66Price
3,171Shares
−13%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Mon, Sep 25. Filed Wed, Sep 27, 5:43 PM ET, after the close. Not investment advice.